Top Markets
Coin of the day
Gwo Xi Stem Cell Applied Technology Co. , Ltd Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology Co. , Ltd

6704
Kedudukan dalam Saham #24642
Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem... Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for osteoarthritis, alongside GXIPC1, another allogeneic fat-derived stem cell treatment in early-stage Phase I trials for diabetes. Established in 2011, the company maintains its headquarters in Zhubei, Taiwan.
Harga Saham
$0.60736143
Modal Pasaran
$58.28M
Perubahan (1 hari)
-1.04%
Perubahan (1 tahun)
-21.09%
Negara
TW
Perdagangan Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)

Kategori

Sejarah harga saham bagi Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)
Harga penutupan tertinggi: $0.61 pada 2026-08-01

Harga penutupan terendah: $1.47 pada 2023-04-01
Sejarah harga saham Gwo Xi Stem Cell Applied Technology Co. , Ltd dari 2023 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -11.38%
2025 1.08%
2024 -27.87%
2023 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$550.26 38.44%
US
$1.05K 58.16%
NL
$148.90 467.89%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH